Globus MedicalGMED +5.48%97 OCF Yield % is 7.16 as of Jul. 03, 2026, which is 97% above its 10-year median of 3.64. GuruFocus rates GMED with a GF Score™ of 97/100 and a GF Value™ of $98.68 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Globus Medical ranks better than 77.52% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Globus Medical OCF Yield % Related Terms
Globus Medical OCF Yield % Historical Data
* Premium members only.
The historical data trend for Globus Medical's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Globus Medical's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Globus Medical OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Globus Medical's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Globus Medical (GMED) has a OCF Yield % of 7.16 as of Jul. 03, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Globus Medical and its competitors. This is 97% above median its historical median of 3.64. Over the past decade, Globus Medical's OCF Yield % has ranged from 2.19 to 9.34. According to the industry distribution chart, Globus Medical ranks #192 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 22.5%.
Is Globus Medical's OCF Yield % too high?
Globus Medical's current OCF Yield % of 7.16 is 97% above median its 10-year median of 3.64. Over the past 10 years, this metric has ranged from a low of 2.19 to a high of 9.34. The Medical Devices & Instruments industry median OCF Yield % is 1.68. Globus Medical's value of 7.16 is 326.2% above this industry median. Based on the distribution chart, Globus Medical ranks #192 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Globus Medical has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's OCF Yield % compare to PEN and PODD?
According to the Medical Devices & Instruments industry distribution chart, Globus Medical ranks #192 out of 854 companies for OCF Yield %. This places Globus Medical in the top 23% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.68. Globus Medical's value of 7.16 is 326.2% above this benchmark. Historically, Globus Medical's own OCF Yield % has ranged from 2.19 to 9.34 over the past decade. While the company's 10-year median is 3.64 vs. the industry median of 1.68, Globus Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.68, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Globus Medical's current OCF Yield % of 7.16 is 326.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Globus Medical and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Globus Medical's current OCF Yield % is 7.16, which is 97% above median its own 10-year median of 3.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is $98.68, compared to a current price of $80.12 — trading 18.8% below its estimated fair value. The current OCF Yield % is 7.16, which is 97% above median its 10-year median of 3.64 and 326.2% above the Medical Devices & Instruments industry median of 1.68. Globus Medical's overall GF Score™ is 97/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Globus Medical (GMED), the current OCF Yield % is 7.16 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Globus Medical (GMED) Overvalued in 2026?
Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued.
The current stock price of $80.12 is trading 18.8% below its estimated GF Value™ of $98.68.
GuruFocus considers Globus Medical to be Modestly Undervalued.
Key valuation signals for GMED:
OCF Yield %: 7.16 (97% above median its 10-year median of 3.64)
GF Value™: $98.68 vs. price of $80.12 (18.8% below fair value)
Industry Position: 326.2% above the Medical Devices & Instruments median (#192 of 854)
No single metric tells the full story. See the GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
97GF Score
Get the complete analysis for GMED
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GMED has been successfully added to your 
